A descriptive analysis of pharmacological management of aggression and/or agitation in patients with traumatic brain injury in a Southwest Virginia inpatient population

WHAT IS KNOWN AND OBJECTIVE: Traumatic brain injury (TBI) is a major cause of disability, and it has been associated with agitation and aggression. In a previous study, we reviewed the literature to identify evidence‐based pharmacological agents for treatment of agitation in TBI. Based on the result...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahmani, Elham, Lemelle, Tricia, Sharp, Hunter, Smarbafzadeh, Ehsan, Kablinger, Anita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087613/
https://www.ncbi.nlm.nih.gov/pubmed/36543254
http://dx.doi.org/10.1111/jcpt.13754

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087613/
https://www.ncbi.nlm.nih.gov/pubmed/36543254
http://dx.doi.org/10.1111/jcpt.13754

Ejemplares similares